Small intestine cancer natural history, complications, and prognosis
|
Small intestine cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Small intestine cancer natural history, complications, and prognosis On the Web |
|
American Roentgen Ray Society Images of Small intestine cancer natural history, complications, and prognosis |
|
FDA on Small intestine cancer natural history, complications, and prognosis |
|
CDC on Small intestine cancer natural history, complications, and prognosis |
|
Small intestine cancer natural history, complications, and prognosis in the news |
|
Blogs on Small intestine cancer natural history, complications, and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
Depending on the extent of the tumor at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor. Small intestine adenocarcinoma is associated with a 5 year survival rate of 20%.
Prognosis
- The overall 5-year survival rate for resectable adenocarcinoma is only 20%. The 5-year survival rate for resectable leiomyosarcoma, the most common primary sarcoma of the small intestine, is approximately 50%.
- The prognosis of small intestine cancer depends on the following:
- Whether or not the tumor can be removed by surgery
- The stage of the cancer, the size of the tumor, whether the cancer has spread outside the small intestine
- The patient’s general health
- Whether the cancer has just been diagnosed or has recurred
- Clinical features and natural history of small intestinal tumors have not been clearly studied, as its a rare condition.[1]
- Adenocarcinoma of the duodenum is associated with low overall survival rate compared to the tumors located in Jejunum and ileum.[2]
References
- ↑ Higashi D, Ishibashi Y, Tamura T, Nii K, Egawa Y, Koga M, Tomiyasu T, Harimura T, Tanaka R, Futatsuki R, Noda S, Futami K, Maekawa T, Takaki Y, Hirai F, Matsui T (August 2010). "Clinical features of and chemotherapy for cancer of the small intestine". Anticancer Res. 30 (8): 3193–7. PMID 20871040.
- ↑ Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J (August 2004). "Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients". Cancer. 101 (3): 518–26. doi:10.1002/cncr.20404. PMID 15274064.